A major factor holding back development of wearable biosensors for health monitoring is the lack of a lightweight, long-lasting power supply. Now scientists at the University of Massachusetts Amherst led by materials chemist Trisha L. Andrew report that they have developed a method for making a charge-storing system that is easily integrated into clothing for “embroidering a charge-storing pattern onto any garment.”
California, Tesla’s home state, is currently on fire as the current wildfire season is proving to be particularly devastating.
CEO Elon Musk has authorized Tesla employees to provide assistance for the wildfires and not worry about payment.
Several wildfires have been extremely destructive in California this week.
Grunya Sukhareva characterized autism nearly two decades before Austrian doctors Leo Kanner and Hans Asperger.
A small device that contains human cells in a 3D matrix represents a giant leap in the ability of scientists to test how those cells respond to stresses, drugs and genetic changes. About the size of a thumb drive, the devices are known as tissue chips or organs on chips.
A series of investigations to test tissue chips in microgravity aboard the International Space Station is planned through a collaboration between the National Center for Advancing Translational Sciences (NCATS) at the National Institutes for Health (NIH) and the Center for the Advancement of Science in Space (CASIS) in partnership with NASA. The Tissue Chips in Space initiative seeks to better understand the role of microgravity on human health and disease and to translate that understanding to improved human health on Earth.
“Spaceflight causes many significant changes in the human body,” said Liz Warren, associate program scientist at CASIS. “We expect tissue chips in space to behave much like an astronaut’s body, experiencing the same kind of rapid change.”
The economic toll of this superbug crisis is huge: In the United States alone the health-care costs dealing with antimicrobial resistance could reach $65 billion by 2050, according to the OECD report. That is more than the flu, HIV and tuberculosis. If projections are correct, resistance to backup antibiotics will be 70 percent higher in 2030 compared to 2005 in OECD countries. In the same period, resistance to third-line treatments will double across EU countries.
A new report released Wednesday from the OECD estimates that antimicrobial resistant infection is on track to kill 30,000 Americans per year by 2050. The OECD is calling on the US and other rich countries to implement 5 simple reforms to save lives.